The management of renal cell carcinoma
- 1 June 1994
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 16 (3) , 181-200
- https://doi.org/10.1016/1040-8428(94)90070-1
Abstract
No abstract availableThis publication has 135 references indexed in Scilit:
- Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinomaEuropean Journal Of Cancer, 1992
- Recombinant interleukin-2 in metastatic renal cell carcinoma—A European multicentre phase II studyEuropean Journal of Cancer and Clinical Oncology, 1991
- Phase II Trial of High-Dose Intermittent Interleukin-2 in Metastatic Renal Cell Carcinoma: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1990
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Chronic renal failure: A significant risk factor in the development of acquired renal cysts and renal cell carcinoma. Case reports and review of the literatureCancer, 1986
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaNew England Journal of Medicine, 1984
- Hereditary Renal-Cell Carcinoma Associated with a Chromosomal TranslocationNew England Journal of Medicine, 1979